Skip to main content
Top
Published in: Trials 1/2006

Open Access 01-12-2006 | Research

Duty, desire or indifference? A qualitative study of patient decisions about recruitment to an epilepsy treatment trial

Authors: Krysia Canvin, Ann Jacoby

Published in: Trials | Issue 1/2006

Login to get access

Abstract

Background

Epilepsy is a common neurological condition, in which drugs are the mainstay of treatment and drugs trials are commonplace. Understanding why patients might or might not opt to participate in epilepsy drug trials is therefore of some importance, particularly at a time of rapid drug development and testing; and the findings may also have wider applicability. This study examined the role of patient perceptions in the decision-making process about recruitment to an RCT (the SANAD Trial) that compared different antiepileptic drug treatments for the management of new-onset seizures and epilepsy.

Methods

In-depth interviews with 23 patients recruited from four study centres. All interviews were tape-recorded and transcribed; the transcripts were analysed thematically using a qualitative data analysis package.

Results

Of the nineteen informants who agreed to participate in SANAD, none agreed for purely altruistic reasons. The four informants who declined all did so for very specific reasons of self-interest. Informants' perceptions of the nature of the trial, of the drugs subject to trial, and of their own involvement were all highly influential in their decision-making. Informants either perceived the trial as potentially beneficial or unlikely to be harmful, and so agreed to participate; or as potentially harmful or unlikely to be beneficial and so declined to participate.

Conclusion

Most patients applied 'weak altruism', while maintaining self-interest. An emphasis on the safety and equivalence of treatments allowed some patients to be indifferent to the question of involvement. There was evidence that some participants were subject to 'therapeutic misconceptions'. The findings highlight the individual nature of trials but nonetheless raise some generic issues in relation to their design and conduct.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chard JA, Lilford RJ: The use of equipoise in clinical trials. Soc Sci Med. 1998, 47: 891-98. 10.1016/S0277-9536(98)00153-1.CrossRefPubMed Chard JA, Lilford RJ: The use of equipoise in clinical trials. Soc Sci Med. 1998, 47: 891-98. 10.1016/S0277-9536(98)00153-1.CrossRefPubMed
2.
go back to reference Prescott R, Counsell C, Gillespie W, Grant AM, Russell IT, Kiauka S, Colthart IR, Ross S, Shepherd SM, Russell D: Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess. 1999, 3 (20): Prescott R, Counsell C, Gillespie W, Grant AM, Russell IT, Kiauka S, Colthart IR, Ross S, Shepherd SM, Russell D: Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess. 1999, 3 (20):
3.
go back to reference Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R: Barriers to Participation in Randomised Controlled Trials: A Systematic Review. J Clin Epidemiol. 1999, 52 (12): 1143-1156. 10.1016/S0895-4356(99)00141-9.CrossRefPubMed Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R: Barriers to Participation in Randomised Controlled Trials: A Systematic Review. J Clin Epidemiol. 1999, 52 (12): 1143-1156. 10.1016/S0895-4356(99)00141-9.CrossRefPubMed
4.
go back to reference Robinson EJ, Kerr C, Stevens A, Lilford R, Braunholtz D, Edwards S: Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials. Soc Sci Med. 2004, 58 (4): 811-824. 10.1016/S0277-9536(03)00255-7.CrossRefPubMed Robinson EJ, Kerr C, Stevens A, Lilford R, Braunholtz D, Edwards S: Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials. Soc Sci Med. 2004, 58 (4): 811-824. 10.1016/S0277-9536(03)00255-7.CrossRefPubMed
5.
go back to reference Fallowfield LJ, Jenkins V, Brennan C, Sawtell M, Moynihan C, Souhami RL: Attitudes of patients to randomised clinical trials of cancer therapy. Eur J Cancer. 1998, 34 (10): 1544-1559. 10.1016/S0959-8049(98)00193-2.CrossRef Fallowfield LJ, Jenkins V, Brennan C, Sawtell M, Moynihan C, Souhami RL: Attitudes of patients to randomised clinical trials of cancer therapy. Eur J Cancer. 1998, 34 (10): 1544-1559. 10.1016/S0959-8049(98)00193-2.CrossRef
6.
go back to reference Slevin M, Mossman J, Bowling A, Leonard R, Steward W, Harper P, McIllmurray M, Thatcher N: Volunteers or victims: patients' views of randomised cancer clinical trials. Br J Cancer. 1995, 71: 1270-1274.CrossRefPubMedPubMedCentral Slevin M, Mossman J, Bowling A, Leonard R, Steward W, Harper P, McIllmurray M, Thatcher N: Volunteers or victims: patients' views of randomised cancer clinical trials. Br J Cancer. 1995, 71: 1270-1274.CrossRefPubMedPubMedCentral
7.
go back to reference Bevan EG, Chee LC, McGhee SM, McInnes GT: Patients' attitudes to participation in clinical trials. Br J Pharmacol. 1993, 35: 201-7. Bevan EG, Chee LC, McGhee SM, McInnes GT: Patients' attitudes to participation in clinical trials. Br J Pharmacol. 1993, 35: 201-7.
8.
go back to reference Larson E, McGuire DB: Patient experiences with research in a tertiary care setting. Nurs Res. 1990, 39 (3): 168-71. 10.1097/00006199-199005000-00014.CrossRefPubMed Larson E, McGuire DB: Patient experiences with research in a tertiary care setting. Nurs Res. 1990, 39 (3): 168-71. 10.1097/00006199-199005000-00014.CrossRefPubMed
9.
go back to reference Cassileth BR, Lusk EJ, Miller DS, Hurwitz S: Attitudes toward clinical trials among patients and the public. JAMA. 1982, 248 (8): 968-970. 10.1001/jama.248.8.968.CrossRefPubMed Cassileth BR, Lusk EJ, Miller DS, Hurwitz S: Attitudes toward clinical trials among patients and the public. JAMA. 1982, 248 (8): 968-970. 10.1001/jama.248.8.968.CrossRefPubMed
10.
go back to reference Hudmon KS, Stoltzfus C, Chamberlain RM, Lorimor RJ, Steinbach G, Winn RJ: Participants' Perceptions of a Phase I Colon Cancer Chemoprevention Trial. Control Clin Trials. 1996, 17: 494-508. 10.1016/S0197-2456(96)00063-3.CrossRefPubMed Hudmon KS, Stoltzfus C, Chamberlain RM, Lorimor RJ, Steinbach G, Winn RJ: Participants' Perceptions of a Phase I Colon Cancer Chemoprevention Trial. Control Clin Trials. 1996, 17: 494-508. 10.1016/S0197-2456(96)00063-3.CrossRefPubMed
11.
go back to reference Mattson ME, Curb JD, McArdle R: Participation in a clinical trial: the patients' point of view. Control Clin Trials. 1985, 6: 156-167. 10.1016/0197-2456(85)90121-7.CrossRefPubMed Mattson ME, Curb JD, McArdle R: Participation in a clinical trial: the patients' point of view. Control Clin Trials. 1985, 6: 156-167. 10.1016/0197-2456(85)90121-7.CrossRefPubMed
12.
go back to reference Cunny KA, Miller HW: Participation in clinical drug trials: Motivations and Barriers. Clin Ther. 1994, 16 (2): 273-282.PubMed Cunny KA, Miller HW: Participation in clinical drug trials: Motivations and Barriers. Clin Ther. 1994, 16 (2): 273-282.PubMed
13.
go back to reference Welton AJ, Vickers MR, Cooper JA, Meade TW, Marteau TM: Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ. 1999, 318: 1114-7.CrossRefPubMedPubMedCentral Welton AJ, Vickers MR, Cooper JA, Meade TW, Marteau TM: Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ. 1999, 318: 1114-7.CrossRefPubMedPubMedCentral
14.
go back to reference Searight HR, Miller CK: Remembering and interpreting informed consent: a qualitative study of drug trial participants. J Am Board Fam Pract. 1996, 9 (1): 14-22.PubMed Searight HR, Miller CK: Remembering and interpreting informed consent: a qualitative study of drug trial participants. J Am Board Fam Pract. 1996, 9 (1): 14-22.PubMed
15.
go back to reference Sanchez S, Salazar G, Tijero M, Diaz S: Informed consent procedures : responsibilities of researchers in developing countries. Bioethics. 2001, 15 (5–6): 398-412. 10.1111/1467-8519.00250.CrossRefPubMed Sanchez S, Salazar G, Tijero M, Diaz S: Informed consent procedures : responsibilities of researchers in developing countries. Bioethics. 2001, 15 (5–6): 398-412. 10.1111/1467-8519.00250.CrossRefPubMed
16.
go back to reference Lawton J, Fox A, Fox C, Kinmonth AL: Participating in the United Kingdom Prospective Diabetes Study (UKPDS): a qualitative study of patients' experiences. [see comment]. Br J Gen Pract. 2003, 53 (490): 394-8.PubMedPubMedCentral Lawton J, Fox A, Fox C, Kinmonth AL: Participating in the United Kingdom Prospective Diabetes Study (UKPDS): a qualitative study of patients' experiences. [see comment]. Br J Gen Pract. 2003, 53 (490): 394-8.PubMedPubMedCentral
17.
go back to reference Snowdon C, Garcia J, Elbourne D: Making sense of randomisation: responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med. 1997, 45: 1337-55. 10.1016/S0277-9536(97)00063-4.CrossRefPubMed Snowdon C, Garcia J, Elbourne D: Making sense of randomisation: responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med. 1997, 45: 1337-55. 10.1016/S0277-9536(97)00063-4.CrossRefPubMed
18.
go back to reference Schutta KM, Burnett CB: Factors that influence a patient's decision to participate in a phase I cancer trial. Oncol Nurs Forum. 2000, 27: 1435-38.PubMed Schutta KM, Burnett CB: Factors that influence a patient's decision to participate in a phase I cancer trial. Oncol Nurs Forum. 2000, 27: 1435-38.PubMed
19.
go back to reference Featherstone K, Donovan JL: Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. BMJ. 1998, 317: 1177-1180.CrossRefPubMedPubMedCentral Featherstone K, Donovan JL: Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. BMJ. 1998, 317: 1177-1180.CrossRefPubMedPubMedCentral
20.
go back to reference Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC: Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. Control Clin Trials. 2003, 24: 272-282. 10.1016/S0197-2456(03)00020-5.CrossRefPubMed Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC: Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. Control Clin Trials. 2003, 24: 272-282. 10.1016/S0197-2456(03)00020-5.CrossRefPubMed
21.
go back to reference Mohanna K, Tunna K: Withholding consent to participate in clinical trials: decisions of pregnant women. Br J Obstet Gynaecol. 1999, 106 (9): 892-7.CrossRefPubMed Mohanna K, Tunna K: Withholding consent to participate in clinical trials: decisions of pregnant women. Br J Obstet Gynaecol. 1999, 106 (9): 892-7.CrossRefPubMed
22.
go back to reference Ellis PM: Attitudes towards and participation in randomised controlled clinical trials in oncology: A review of the literature. Ann Oncol. 2000, 11: 939-945. 10.1023/A:1008342222205.CrossRefPubMed Ellis PM: Attitudes towards and participation in randomised controlled clinical trials in oncology: A review of the literature. Ann Oncol. 2000, 11: 939-945. 10.1023/A:1008342222205.CrossRefPubMed
23.
go back to reference Gammelgaard A, Rossel P, Mortensen OS: Patients' perceptions of informed consent in acute myocardial infarction research: a Danish study. Soc Sci Med. 2004, 58: 2313-24. 10.1016/j.socscimed.2003.08.023.CrossRefPubMed Gammelgaard A, Rossel P, Mortensen OS: Patients' perceptions of informed consent in acute myocardial infarction research: a Danish study. Soc Sci Med. 2004, 58: 2313-24. 10.1016/j.socscimed.2003.08.023.CrossRefPubMed
24.
go back to reference Jenkins V, Fallowfield L: Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer. 2000, 82 (11): 1783-88. 10.1054/bjoc.2000.1142.CrossRefPubMedPubMedCentral Jenkins V, Fallowfield L: Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer. 2000, 82 (11): 1783-88. 10.1054/bjoc.2000.1142.CrossRefPubMedPubMedCentral
25.
go back to reference Emanuel EJ, Patterson WB: Ethics of randomized clinical trials. J Clin Oncol. 1998, 16 (1): 365-71.PubMed Emanuel EJ, Patterson WB: Ethics of randomized clinical trials. J Clin Oncol. 1998, 16 (1): 365-71.PubMed
26.
go back to reference Hepworth J, Paine B, Miles H, Marley J, MacLennan A: The willingness of women to participate in a long-term trial of hormone replacement therapy: a qualitative study using focus groups. Psychol Health Med. 2002, 7 (4): 469-76.CrossRef Hepworth J, Paine B, Miles H, Marley J, MacLennan A: The willingness of women to participate in a long-term trial of hormone replacement therapy: a qualitative study using focus groups. Psychol Health Med. 2002, 7 (4): 469-76.CrossRef
27.
go back to reference Edwards SJL, Lilford RJ, Hewison J: The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals. BMJ. 1998, 317: 1209-1212.CrossRefPubMedPubMedCentral Edwards SJL, Lilford RJ, Hewison J: The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals. BMJ. 1998, 317: 1209-1212.CrossRefPubMedPubMedCentral
28.
go back to reference Lidz CW, Appelbaum PS, Grisso T, Renaud M: Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med. 2004, 58: 1689-97. 10.1016/S0277-9536(03)00338-1.CrossRefPubMed Lidz CW, Appelbaum PS, Grisso T, Renaud M: Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med. 2004, 58: 1689-97. 10.1016/S0277-9536(03)00338-1.CrossRefPubMed
29.
go back to reference Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC: Quality of informed consent in cancer clinical trials; a cross-sectional survey. Lancet. 2001, 358: 1772-77. 10.1016/S0140-6736(01)06805-2.CrossRefPubMed Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC: Quality of informed consent in cancer clinical trials; a cross-sectional survey. Lancet. 2001, 358: 1772-77. 10.1016/S0140-6736(01)06805-2.CrossRefPubMed
30.
go back to reference Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, Vinicky JK: The impact of disease severity on the informed consent process in clinical research. Am J Med. 1996, 100: 261-68. 10.1016/S0002-9343(97)89483-1.CrossRefPubMed Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, Vinicky JK: The impact of disease severity on the informed consent process in clinical research. Am J Med. 1996, 100: 261-68. 10.1016/S0002-9343(97)89483-1.CrossRefPubMed
31.
go back to reference Roberts F: Qualitative differences among cancer trial explanations. Soc Sci Med. 2002, 55: 1947-55. 10.1016/S0277-9536(01)00323-9.CrossRefPubMed Roberts F: Qualitative differences among cancer trial explanations. Soc Sci Med. 2002, 55: 1947-55. 10.1016/S0277-9536(01)00323-9.CrossRefPubMed
32.
go back to reference Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, Frankel S, Neal D, Hamdy F: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ. 2002, 325: 766-770. 10.1136/bmj.325.7367.766.CrossRefPubMedPubMedCentral Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, Frankel S, Neal D, Hamdy F: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ. 2002, 325: 766-770. 10.1136/bmj.325.7367.766.CrossRefPubMedPubMedCentral
33.
go back to reference Marson AG, Tudur-Smith C, Gamble C, Shackley P, Williamson PR, Smith DF, Appleton R, Baker GA, Eaton B, Jacoby AJ, Chadwick DW: Comparison of effectiveness and cost-effectiveness of new versus standard antiepileptic drugs The UK SANAD Study. Report to UK Health Technology Assessment Panel. Marson AG, Tudur-Smith C, Gamble C, Shackley P, Williamson PR, Smith DF, Appleton R, Baker GA, Eaton B, Jacoby AJ, Chadwick DW: Comparison of effectiveness and cost-effectiveness of new versus standard antiepileptic drugs The UK SANAD Study. Report to UK Health Technology Assessment Panel.
34.
go back to reference Reynolds EH: ILAE/IBE/WHO Epilepsy Global Campaign History. Epilepsia. 2002, 43: 9-11. 10.1046/j.1528-1157.43.s.6.5.x.CrossRefPubMed Reynolds EH: ILAE/IBE/WHO Epilepsy Global Campaign History. Epilepsia. 2002, 43: 9-11. 10.1046/j.1528-1157.43.s.6.5.x.CrossRefPubMed
35.
go back to reference Sander JWAS, Sillanpaa M: Natural History and Prognosis. Epilepsy: a comprehensive textbook. Edited by: Engel J, Pedley TA. 1997, Philadelphia: Lippincott-Raven, 69-86. Sander JWAS, Sillanpaa M: Natural History and Prognosis. Epilepsy: a comprehensive textbook. Edited by: Engel J, Pedley TA. 1997, Philadelphia: Lippincott-Raven, 69-86.
36.
go back to reference National Institute for Clinical Excellence: Newer drugs for epilepsy in adults. (Technology Appraisal Guidance 76). London. 2004 National Institute for Clinical Excellence: Newer drugs for epilepsy in adults. (Technology Appraisal Guidance 76). London. 2004
37.
go back to reference Strauss A, Corbin J: Basics of qualitative research: Techniques and procedures for developing grounded theory. 1998, Thousand Oaks, CA: Sage, 2 Strauss A, Corbin J: Basics of qualitative research: Techniques and procedures for developing grounded theory. 1998, Thousand Oaks, CA: Sage, 2
38.
39.
go back to reference Zupancic JAF, Gillie P, Streiner DL, Watts JL, Schmidt B: Determinants of parental authorization for involvement of newborn infants in clinical trials. Pediatrics. 1997, 99: 6-11. 10.1542/peds.99.1.e6.CrossRef Zupancic JAF, Gillie P, Streiner DL, Watts JL, Schmidt B: Determinants of parental authorization for involvement of newborn infants in clinical trials. Pediatrics. 1997, 99: 6-11. 10.1542/peds.99.1.e6.CrossRef
40.
go back to reference Harth SS, Thong YH: Sociodemographic and motivational characteristics of parents who volunteer their children for clinical research: a controlled study. BMJ. 1990, 300: 1372-75.CrossRefPubMedPubMedCentral Harth SS, Thong YH: Sociodemographic and motivational characteristics of parents who volunteer their children for clinical research: a controlled study. BMJ. 1990, 300: 1372-75.CrossRefPubMedPubMedCentral
41.
go back to reference Snowdon C: Collaboration, participation and non-participation: decisions about involvement in randomised clinical trials for clinicians and parents in two neonatal trials. PhD thesis. 2005, University of London, London School of Hygiene and Tropical Medicine Snowdon C: Collaboration, participation and non-participation: decisions about involvement in randomised clinical trials for clinicians and parents in two neonatal trials. PhD thesis. 2005, University of London, London School of Hygiene and Tropical Medicine
44.
go back to reference Corrigan O: Empty Ethics: the problem with informed consent. Sociol Health Illn. 2003, 25: 795-814. 10.1046/j.1467-9566.2003.00369.x.CrossRef Corrigan O: Empty Ethics: the problem with informed consent. Sociol Health Illn. 2003, 25: 795-814. 10.1046/j.1467-9566.2003.00369.x.CrossRef
45.
go back to reference Little P: Commentary: presenting unbiased information to patients can be difficult. BMJ. 2002, 325: 766-770. 10.1136/bmj.325.7367.770.CrossRef Little P: Commentary: presenting unbiased information to patients can be difficult. BMJ. 2002, 325: 766-770. 10.1136/bmj.325.7367.770.CrossRef
46.
go back to reference Jenkins VA, Fallowfield LJ, Souhami A, Sawtell M: How do doctors explain randomised controlled trials to their patients?. Eur J Cancer. 1999, 35 (8): 1187-1193. 10.1016/S0959-8049(99)00116-1.CrossRefPubMed Jenkins VA, Fallowfield LJ, Souhami A, Sawtell M: How do doctors explain randomised controlled trials to their patients?. Eur J Cancer. 1999, 35 (8): 1187-1193. 10.1016/S0959-8049(99)00116-1.CrossRefPubMed
47.
go back to reference Ward P, Coates A: We shed tears, but there is no one to wipe them up for us: narratives of (mis)trust in a materially deprived community. Health (London). 2006, 10 (3): 283-301. 10.1177/1363459306064481.CrossRef Ward P, Coates A: We shed tears, but there is no one to wipe them up for us: narratives of (mis)trust in a materially deprived community. Health (London). 2006, 10 (3): 283-301. 10.1177/1363459306064481.CrossRef
48.
go back to reference Scambler S: Health and Social Change: a critical theory. 2002, Buckingham: Open University Press Scambler S: Health and Social Change: a critical theory. 2002, Buckingham: Open University Press
49.
go back to reference Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D: Quality of life of people with epilepsy: a European Study. Epilepsia. 1997, 38 (3): 353-62. 10.1111/j.1528-1157.1997.tb01128.x.CrossRefPubMed Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D: Quality of life of people with epilepsy: a European Study. Epilepsia. 1997, 38 (3): 353-62. 10.1111/j.1528-1157.1997.tb01128.x.CrossRefPubMed
50.
go back to reference Verheggen FWSM, van Wijmen FC: Informed consent in clinical trials. Health Policy. 1996, 36: 131-53. 10.1016/0168-8510(95)00805-5.CrossRefPubMed Verheggen FWSM, van Wijmen FC: Informed consent in clinical trials. Health Policy. 1996, 36: 131-53. 10.1016/0168-8510(95)00805-5.CrossRefPubMed
Metadata
Title
Duty, desire or indifference? A qualitative study of patient decisions about recruitment to an epilepsy treatment trial
Authors
Krysia Canvin
Ann Jacoby
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Trials / Issue 1/2006
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-7-32

Other articles of this Issue 1/2006

Trials 1/2006 Go to the issue